Ki67 and CD30 Predict Survival in Non-Transformed Mycosis Fungoides

被引：0
|
作者：
Edinger, J. T. [1 ]
Clark, B. Z. [1 ]
Pucevich, B. E. [1 ]
Geskin, L. J. [1 ]
Swerdlow, S. H. [1 ]
机构：
[1] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
来源：
LABORATORY INVESTIGATION | 2009年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1188
引用
收藏
页码：261A / 261A
页数：1
相关论文
共 50 条
  • [21] Immunohistochemistry Expression of P53, Ki67, CD30, and CD117 and Presence of Clinical Metastasis at Diagnosis of Testicular Seminoma
    Gallegos, Ivan
    Pablo Valdevenito, Juan
    Miranda, Ruben
    Fernandez, Cristina
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2011, 19 (02) : 147 - 152
  • [22] High intraindividual variability of CD30 expression in mycosis fungoides: implications for diagnostic evaluation and therapy
    Mitteldorf, Christina
    Kampa, Franziska
    Stroebel, Philipp
    Schoen, Michael P.
    Kempf, Werner
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : S26 - S26
  • [23] High Soluble CD30, CD25, and IL-6 May Identify Patients with Worse Survival in CD30+ Cutaneous Lymphomas and Early Mycosis Fungoides
    Kadin, Marshall E.
    Pavlov, Igor Y.
    Delgado, Julio C.
    Vonderheid, Eric C.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 (03) : 703 - 710
  • [24] Facies leontina- rare Case of a folliculo tropical Mycosis fungoides with CD30 positive Transformation
    Kellner, I.
    Geyer, M.
    Weisse, F.
    Herbst, A.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 : 2 - 2
  • [25] Ki67 antigen and PCNA proliferation markers predict survival in anorectal malignant melanoma
    Ben-Izhak, O
    Bar-Chana, M
    Sussman, L
    Dobiner, V
    Sandbank, J
    Cagnano, M
    Cohen, H
    Sabo, E
    HISTOPATHOLOGY, 2002, 41 (06) : 519 - 525
  • [26] CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells
    Herszfeld, D
    Wolvetang, E
    Langton-Bunker, E
    Chung, TL
    Filipczyk, AA
    Houssami, S
    Jamshidi, P
    Koh, K
    Laslett, AL
    Michalska, A
    Nguyen, L
    Reubinoff, BE
    Tellis, I
    Auerbach, JM
    Ording, CJ
    Looijenga, LHJ
    Pera, MF
    NATURE BIOTECHNOLOGY, 2006, 24 (03) : 351 - 357
  • [27] CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells
    Daniella Herszfeld
    Ernst Wolvetang
    Emma Langton-Bunker
    Tung-Liang Chung
    Adam A Filipczyk
    Souheir Houssami
    Pegah Jamshidi
    Karen Koh
    Andrew L Laslett
    Anna Michalska
    Linh Nguyen
    Benjamin E Reubinoff
    Irene Tellis
    Jonathan M Auerbach
    Carol J Ording
    Leendert H J Looijenga
    Martin F Pera
    Nature Biotechnology, 2006, 24 : 351 - 357
  • [28] CD4/CD8 double-negative early-stage mycosis fungoides with CD30 expression
    Shon, Uri
    Yun, Dea Kwan
    Seong, Gi Hyun
    Park, Byung Cheol
    Kim, Myung Hwa
    Lee, Dong Yoon
    JOURNAL OF CUTANEOUS PATHOLOGY, 2021, 48 (04) : 587 - 589
  • [29] Brentuximab Vedotin Demonstrates Significant Clinical Activity in Relapsed or Refractory Mycosis Fungoides with Variable CD30 Expression
    Krathen, Michael
    Sundram, Uma
    Bashey, Sameer
    Sutherland, Katherine
    Salva, Katrin
    Wood, Gary S.
    Advani, Ranjana H.
    Hoppe, Richard T.
    Reddy, Sunil
    Armstrong, Randall
    Nagpal, Seema
    Pulitzer, Melissa
    Horwitz, Steven M.
    Kim, Youn H.
    BLOOD, 2012, 120 (21)
  • [30] A case of primary cutaneous CD30 positive anaplastic large cell lymphoma in a patient with granulomatous mycosis fungoides
    Seol, J. E.
    Cho, G. J.
    Kim, J. U.
    Park, S. H.
    Jin, W. J.
    Kim, H.
    HONG KONG JOURNAL OF DERMATOLOGY & VENEREOLOGY, 2020, 28 (03): : 115 - 120
12345